697 |
ASSIST: Early Eptifibatide Administration in Patients with AMI Undergoing Primary PCI After Thienopyridine Loading |
Michel Le May |
Dec. 09. 08 |
696 |
NAPLES: Bivalirudin vs. Unfractionated Heparin plus Tirofiban in Patients with Diabetes Undergoing Elective PCI |
Carlo Briguori |
Dec. 09. 08 |
695 |
ARNO: Bivalirudin vs. Unfractionated Heparin plus Protamine in Patients Undergoing Elective PCI |
David Antoniucci |
Dec. 09. 08 |
694 |
PREPARE: Proximal Microcirculatory Protection in Patients with AMI Undergoing Primary PCI |
Karel Koch |
Dec. 09. 08 |
693 |
HORIZONS AMI: Bivalirudin vs. Unfractionated Heparin plus GPIIb/IIIa Inhibitors in STEMI [1] |
Roxana Mehran |
Dec. 09. 08 |
692 |
HORIZONS AMI AMI: Prospective Randomized Trials of Paclitaxel-Eluting Stents vs. BMS in Patients with STEMI |
Gregg W. Stone |
Dec. 09. 08 |
691 |
COOL RCN : Randomized Trail of Systemic Hypothermia for Prevention of Radiocontrast Nephropathy |
Gregg W. Stone |
Dec. 09. 08 |
690 |
SOS: Randomized Trials of Paclitaxel-Eluting vs. BMS in SVG Lesions |
Emmanouil Brilakis |
Dec. 09. 08 |
689 |
ODESSA: Using OCT to Evaluate Strut Coverage of Sirolimus-, Paclitaxel- & Zotarolimus- Eluting Stents |
Giulio Guagliumi |
Dec. 09. 08 |
688 |
ENDEAVOR IV: 2-Year FU Comparing Zotarolimus- vs. Paclitaxel-Eluting Stents |
Martin Bert Leon |
Dec. 09. 08 |